摘要:
The invention encompasses a process for making compounds of Formula (I) useful in the treatment of inflammation and other cyclooxygenase-2 mediated diseases.
摘要:
The present invention is directed to a process to synthesize 6-[1-methyl-1-(methylsulfonyl)ethyl]-8-[3(E)-2-[3-methyl-1,2,4-oxadizol-5-yl]-2-[4-(methylsulfonyl)phenyl]ethenyl]phenyl]quinoline and its benzenesulfonic acid salt.
摘要:
The present invention is directed to a process of making spirocycles of general structural formula (I), where R1 is selected from the group consisting of CO-CO1-3 alkyl, cyano, carboxy, carboxy C1-6 alkyl ester, carboxamide, C1-6 alkyl sulfinyl, C1-6 alkyl sulfonyl, C1-6 methanesulfonamide and halogen; R2 is selected from the group consisting of keto or alcohol, R3 is cyano, resulting in compounds which are Class III antiarrhythmic.
摘要:
The present invention is directed to a process to synthesize 6-[1-methyl-1-(methylsulfonyl)ethyl]-8-[3(E)-2-[3-methyl-1,2,4-oxadizol-5-yl]-2-[4-(methylsulfonyl)phenyl]ethenyl]phenyl]quinoline and its benzenesulfonic acid salt.
摘要:
The invention encompasses a process for making compounds of Formula (I) useful in the treatment of inflammation and other cyclooxygenase-2 mediated diseases.